(Q39545354)

English

Inhibition of acid ceramidase by a 2-substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N-(4-hydroxyphenyl) retinamide

scientific article published on 28 December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Inhibition of acid ceramidase by a 2-substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N-(4-hydroxyphenyl) retinamide (English)

1 reference

Europe PubMed Central

12 September 2017

oleic monoethanolamide

1 reference

ChEBI release 2020-05-28

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Valérie Gouazé-Andersson

1

1 reference

Europe PubMed Central

12 September 2017

Margaret Flowers

2

1 reference

Europe PubMed Central

12 September 2017

Ramin Karimi

3

1 reference

Europe PubMed Central

12 September 2017

Gemma Fabriás

4

1 reference

Europe PubMed Central

12 September 2017

Antonio Delgado

5

1 reference

Europe PubMed Central

12 September 2017

Josefina Casas

6

1 reference

Europe PubMed Central

12 September 2017

Myles C Cabot

7

1 reference

Europe PubMed Central

12 September 2017

publication date

28 December 2010

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

71

1 reference

Europe PubMed Central

12 September 2017

10

1 reference

Europe PubMed Central

12 September 2017

1064-1073

1 reference

Europe PubMed Central

12 September 2017

Technological advances in radiotherapy for the treatment of localised prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Human acid ceramidase is overexpressed but not mutated in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Ceramidase Deficiency in Farber's Disease (Lipogranulomatosis)

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Human acid ceramidase: processing, glycosylation, and lysosomal targeting

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Ceramide: an intracellular signal for apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Ceramide signalling: regulatory role in cell proliferation, differentiation and apoptosis in human epidermis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Importance of C16 ceramide accumulation during apoptosis in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Cytotoxicity and acid ceramidase inhibitory activity of 2-substituted aminoethanol amides.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Mechanistic studies of the effects of the retinoid N-(4-hydroxyphenyl)retinamide on prostate cancer cell growth and apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Synthesis of a novel ceramide analogue and its use in a high-throughput fluorogenic assay for ceramidases

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Accumulation of glucosylceramides in multidrug-resistant cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Increasing intracellular ceramide: an approach that enhances the cytotoxic response in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Biologically active sphingolipids in cancer pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Oxidative stress and apoptosis: impact on cancer therapy.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Altered sphingolipid metabolism in N-(4-hydroxyphenyl)-retinamide-resistant A2780 human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Targeting ceramide metabolism--a strategy for overcoming drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21321

21 January 2018

Identifiers

10.1002/PROS.21321

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39545354&oldid=1837628694"